Administration of IL-1Ra chitosan nanoparticles enhances the therapeutic efficacy of mesenchymal stem cell transplantation in acute liver failure

Archives of Medical Research

Volumn 44, Issue 5, 2013, Pages 370-379

  Xiao, Jiang qiang ^a,b   Shi, Xiao lei ^a,b   Ma, Hu cheng ^a,b   Tan, Jia jun ^a   Lin zhang, ^c   Xu, Qian ^c   Ding, Yi tao ^a,b  

^a THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^b Jiangsu Province's Key Medical Center for Hepatobiliary Disease   (China)

^c SOUTHEAST UNIVERSITY   (China)

Author keywords

Acute liver failure; Cell transplantation; Chitosan nanoparticles; IL 1Ra; Mesenchymal stem cells

Indexed keywords

CHITOSAN; FLUORESCEIN ISOTHIOCYANATE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; NANOPARTICLE; SCATTER FACTOR; VASCULOTROPIN; CYTOKINE; DELAYED RELEASE FORMULATION; DRUG CARRIER;

ACUTE LIVER FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LIVER CELL; LIVER FUNCTION; MESENCHYMAL STEM CELL TRANSPLANTATION; MINIPIG; NONHUMAN; PORTAL VEIN; RAT; SCANNING ELECTRON MICROSCOPE; ANIMAL; CELL CULTURE; CHEMICALLY INDUCED; DELAYED RELEASE FORMULATION; DRUG EFFECTS; DRUG POTENTIATION; LIVER FAILURE, ACUTE; MESENCHYMAL STROMA CELL; PATHOLOGY; PROCEDURES; RANDOMIZATION; SECRETION (PROCESS); SWINE;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CHITOSAN; CYTOKINES; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG SYNERGISM; HEPATOCYTES; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LIVER FAILURE, ACUTE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NANOPARTICLES; RANDOM ALLOCATION; SWINE;

EID: 84883328125     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2013.06.004     Document Type: Article

References (29)

1. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
2. Liechty K.W., MacKenzie T.C., Shaaban A.F., et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000, 6:1282-1286.
3. di Bonzo L.V., Ferrero I., Cravanzola C., et al. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. Gut 2008, 57:223-231.
4. Pihlajamaki J., Kuulasmaa T., Kaminska D., et al. Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans. J Hepatol 2012, 56:663-670.
5. Girard S., Kadhim H., Larouche A., et al. Pro-inflammatory disequilibrium of the IL-1 beta/IL-1ra ratio in an experimental model of perinatal brain damages induced by lipopolysaccharide and hypoxia-ischemia. Cytokine 2008, 43:54-62.
6. Di Martino A., Sittinger M., Risbud M.V. Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. Biomaterials 2005, 26:5983-5990.
7. Malviya R., Srivastava P. Preparation, characterization and application of chitosan-alginate based polyelectrolyte complex as fast disintegrating drug delivery carrier. Polim Med 2011, 41:45-54.
8. Schwartz R.E., Reyes M., Koodie L., et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 2002, 109:1291-1302.
9. Petersen B.E., Bowen W.C., Patrene K.D., et al. Bone marrow as a potential source of hepatic oval cells. Science 1999, 284:1168-1170.
10. Johnson K., Zhu S., Tremblay M.S., et al. A stem cell-based approach to cartilage repair. Science 2012, 336:717-721.
11. Jimi E., Hirata S., Osawa K., et al. The current and future therapies of bone regeneration to repair bone defects. Int J Dent 2012, 2012:148261.
12. Samper E., Diez-Juan A., Montero J.A., et al. Cardiac cell therapy: boosting mesenchymal stem cells effects. Stem Cell Rev 2012, 9:266-280.
13. Hynes K., Menicanin D., Gronthos S., et al. Clinical utility of stem cells for periodontal regeneration. Periodontology 2012, 59:203-227.
14. Kim S., Kim H.S., Lee E., et al. Invivo hepatic differentiation potential of human cord blood-derived mesenchymal stem cells. Int J Mol Med 2011, 27:701-706.
15. Parekkadan B., van Poll D., Suganuma K., et al. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One 2007, 2:e941.
16. Arend W.P. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev 2002, 13:323-340.
17. Sgroi A., Gonelle-Gispert C., Morel P., et al. Interleukin-1 receptor antagonist modulates the early phase of liver regeneration after partial hepatectomy in mice. PLoS One 2011, 6:e25442.
18. Granowitz E.V., Porat R., Mier J.W., et al. Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans. Cytokine 1992, 4:353-360.
19. Mahapatro A., Singh D.K. Biodegradable nanoparticles are excellent vehicles for site directed in-vivo delivery of drugs and vaccines. J Nanobiotechnol 2011, 9:55.
20. Nishikawa M., Miyazaki C., Yamashita F., et al. Galactosylated proteins are recognized by the liver according to the surface density of galactose moieties. Am J Physiol 1995, 268:G849-G856.
21. Zhou N., Zan X., Wang Z., et al. Galactosylated chitosan-polycaprolactone nanoparticles for hepatocyte-targeted delivery of curcumin. Carbohydr Polym 2013, 94:420-429.
22. Agudelo D., Sanyakamdhorn S., Nafisi S., et al. Transporting antitumor drug tamoxifen and its metabolites, 4-hydroxytamoxifen and endoxifen by chitosan nanoparticles. PLoS One 2013, 8:e60250.
23. Hu J., Yan D., Gao J., et al. rhIL-1Ra reduces hepatocellular apoptosis in mice with acetaminophen-induced acute liver failure. Lab Invest 2010, 90:1737-1746.
24. Zhu R.Z., Xiang D., Xie C., et al. Protective effect of recombinant human IL-1Ra on CCl4-induced acute liver injury in mice. World J Gastroenterol 2010, 16:2771-2779.
25. Xu Y.X., Chen L., Wang R., et al. Mesenchymal stem cell therapy for diabetes through paracrine mechanisms. Med Hypotheses 2008, 71:390-393.
26. Sato Y., Araki H., Kato J., et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 2005, 106:756-763.
27. Popp F.C., Piso P., Schlitt H.J., et al. Therapeutic potential of bone marrow stem cells for liver diseases. Curr Stem Cell Res Ther 2006, 1:411-418.
28. Kinnaird T., Stabile E., Burnett M.S., et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote invitro and invivo arteriogenesis through paracrine mechanisms. Circ Res 2004, 94:678-685.
29. Chen L., Tredget E.E., Wu P.Y., et al. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 2008, 3:e1886.